Clinical Trial Detail

NCT ID NCT02630420
Title Cetuximab and Savolitinib Treatment of Ras Wild-Type Colorectal Cancer
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Yale University

head and neck squamous cell carcinoma

colorectal cancer


Cetuximab + Savolitinib

Age Groups: adult

Additional content available in CKB BOOST